2.39
4.37%
0.10
시간 외 거래:
2.39
전일 마감가:
$2.29
열려 있는:
$2.29
하루 거래량:
46,359
Relative Volume:
0.62
시가총액:
$65.04M
수익:
-
순이익/손실:
$-14.47M
주가수익비율:
-1.5419
EPS:
-1.55
순현금흐름:
$-12.19M
1주 성능:
-0.83%
1개월 성능:
+5.29%
6개월 성능:
+15.46%
1년 성능:
+83.85%
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
BEAT | 2.39 | 65.04M | 0 | -14.47M | -12.19M | -1.55 |
VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-09-11 | 개시 | Needham | Buy |
2020-09-02 | 개시 | Robert W. Baird | Neutral |
2020-01-08 | 개시 | SunTrust | Buy |
2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2019-04-26 | 재확인 | Dougherty & Company | Buy |
2018-07-26 | 재확인 | Lake Street | Buy |
2018-04-26 | 재확인 | The Benchmark Company | Buy |
2018-02-23 | 재확인 | Dougherty & Company | Buy |
2017-11-08 | 재확인 | Dougherty & Company | Buy |
2017-10-26 | 개시 | Raymond James | Outperform |
2017-10-24 | 개시 | SunTrust | Buy |
2017-08-09 | 재확인 | Dougherty & Company | Buy |
2017-07-19 | 재확인 | The Benchmark Company | Buy |
2017-04-11 | 재확인 | Dougherty & Company | Buy |
2016-12-02 | 개시 | Dougherty & Company | Buy |
2016-09-13 | 개시 | Sidoti | Buy |
2016-08-03 | 재확인 | The Benchmark Company | Buy |
2015-07-28 | 재확인 | Dougherty & Company | Buy |
2013-10-24 | 개시 | The Benchmark Company | Buy |
2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart
Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail
HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer
HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks
HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan
HeartBeam Reports Third Quarter 2024 Results - Yahoo Finance
Spotlight On US Penny Stocks In October 2024 - Simply Wall St
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
Tripp Investments Alters Stake in Betmakers - MSN
Severfield PLC Executes Share Buy-Back on LSE - MSN
HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
HeartBeam Appoints Robert Eno as New CEO - TipRanks
Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
Diamondback Energy (FANG) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR
HeartBeam names Robert Eno as new CEO for growth phase - Investing.com
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
HeartBeam Appoints Robert Eno as Chief Exec - MPO-mag
Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag
Dr. Lance Myers Joins HeartBeam as Chief AI Scientist - MPO-mag
Short Interest in HeartBeam, Inc. (NASDAQ:BEATW) Decreases By 17.6% - Defense World
HeartBeam appoints AI expert Lance Myers as Chief Scientist - Investing.com
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation - Simply Wall St
Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth? - Yahoo Finance
Timothy Cruickshank named HeartBeam CFO - Medical Buyer
Heartbeam stock retains Speculative Buy rating despite near-term risks - Investing.com India
HeartBeam Names Timothy Cruickshank As CFO - MPO-mag
HeartBeam Appoints New CFO to Bolster Financial Strategy - TipRanks
HeartBeam names new CFO to bolster financial strategy By Investing.com - Investing.com Canada
HeartBeam names new CFO to bolster financial strategy - Investing.com
HeartBeam Names Timothy Cruickshank as Chief Financial Officer - StockTitan
HeartBeam stock target unchanged as Benchmark reiterates Speculative Buy rating - Investing.com
Heartbeam director sells over $4,900 in company stock - Investing.com
HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Up 115.4% in August - Defense World
Heartbeam executive sells shares worth over $6,400 - Investing.com
HeartBeam (NASDAQ: BEAT) Announces Positive Study Data For Its AI Program - Barchart
Branislav Vajdic - Forbes
The Globe and Mail - The Globe and Mail
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss - Investing.com
Earnings call: HeartBeam anticipates AIMIGo launch, reports $5M loss By Investing.com - Investing.com UK
HeartBeam Reports Second Quarter 2024 Results - 01Net
BEATHeartBeam, Inc. Latest Stock News & Market Updates - StockTitan
HeartBeam, Inc. (NASDAQ:BEATW) Sees Large Drop in Short Interest - Defense World
HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time - Quantisnow
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):